Glenn Pierce

Dr. Glenn F.
Pierce is an Independent Director at Voyager Therapeutics, Inc., a Chief Medical Officer & Senior Vice President at Bioverativ Therapeutics, Inc., a Member at American Society of Hematology, a Member at Hemostasis & Thrombosis Research Society and a Member at The International Society On Thrombosis & Haemostasis.
He is on the Board of Directors at Voyager Therapeutics, Inc. and World Federation of Hemophilia.
Dr. Pierce was previously employed as a Chief Medical Officer by Ambys Medicines, Inc., an Independent Director by Global Blood Therapeutics, Inc., a Chief Medical Officer & SVP-Global Medical Affairs by Biogen Idec, Inc., a Vice President-Research & Clinical Development by Avigen, Inc., a Vice President-Therapeutic Product Development by Selective Genetics, Inc., a Vice President-PreClinical Development by Prizm Pharmaceuticals, Inc., a Principal by Amgen, Inc., and a Vice President-Applied Research Hematology by Bayer Healthcare LLC.
He also served on the board at National Hemophilia Foundation.
He received his undergraduate degree from Case Western Reserve University, a graduate degree from Washington University in St. Louis and a doctorate degree from Case Western Reserve University.